Animal Microbiome Congress
March 24 - March 25
Animal Microbiome Congress will provide the latest clinical data and key content on the commercialisation of animal microbiome research. The global market is forecasted to grow to $9,775 million by 2028 due to demand for innovation from the rapidly growing meat and pet-healthcare industries. Research indicates that animal microbiome modulation could greatly improve pet health and increase the meat industry’s productivity, while ensuring that it meets its sustainability targets. Consequently, significant profits can be created by overcoming the obstacles in reproducing animal microbiome research in industry and quicker returns can be obtained by translating the more advanced human microbiome technology to modulate the animal microbiome. However, these commercial rewards can only be realised by steering through tough legal obstacles smartly. Our goal is to support smart interactions between business and academia to enable participants to capitalize on the growing global animal microbiome market.